Samuel Bozzette, MD, PhD currently serves as Vice-President, Medical Affairs-Americas for bioMerieux, a leading diagnostics company where he also heads global health economics/outcomes efforts. For most of his career, he has been Senior Natural Scientist at the RAND Corporation and Professor of Medicine and of International Relations at the University of California, San Diego. He was a principal on the national HIV Care and Services Utilization Study and the UCSD program in Public Policy and Biological Threats. He retains an adjunct appointment at UCSD and recently became adjunct Professor of Health Management and Policy at the University of North Carolina. He founded the Health Services Research and Development program at the VA San Diego Medical Center, the Outcomes Group at Amylin Pharmaceuticals, the Evidence and Evaluation Group at the Cerner Corporation’s Population Health Program, and Medical Affairs for the Americas at bioMerieux.
While an academic, Dr. Bozzette has led an internationally recognized program of clinical, services, economic, outcomes, and policy investigations resulting in over 175 publications, including over a dozen in the New England Journal of Medicine. He has also served on policy committees for industry, non-profits, the U.S. government, and other governmental organizations. Dr. Bozzette holds a B.S. from Georgetown University, an M.D. from the University of Rochester, and a Ph.D. in Policy Studies with Distinction in Economics and Quantitative Methods from the RAND Pardee Graduate School. He is certified in Internal Medicine and Infectious Diseases. He is a fellow of the American College of Physicians and the Infectious Diseases Society of America, and an elected member of American Society for Clinical Investigation, the Association of American Physicians, and the Pacific Council on International Policy.